BioSpace News Archive

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

On the back of a $135 million public offering in February, rare disease gene therapy company Krystal Biotech has launched subsidiary Jeune Inc. to promote its gene therapies for aesthetic skin conditions.

Three days after U.S. Food and Drug Administration staff raised safety concerns over Pfizer’s and Eli Lilly’s NGF osteoarthritis drug tanezumab, an advisory panel has also posted its own objections.

Lyell Immunopharma announced this week that it has completed construction of a $65 million, 70,000-square-foot LyFE Manufacturing Center, which the company will use to support clinical trials and meet cell therapy manufacturing needs.

With oncology drugs clocking a disheartening 3.4% success rate, some good news in the field is always appreciated.

Several new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it signed a partnership agreement with Kyowa Kirin Pharmaceutical Research, Inc., a subsidiary of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151)

Optimus Healthcare Services, Inc., announced that it has completed the acquisition of AdhereRx, d/b/a PainScript, a SaaS-based, Telehealth/Chronic Care Compliance platform company in a transaction valued at approximately $4,500,000 as of the market close on March 24, 2021.

Global Prosthetics and Orthopaedics Innovation Leader Recognized by UN Agency for Leadership in Patents for Conventional and Emerging Mobility Assistive Technologies

Bulgarian health and wellness brand Muno-Vax is trying to raise the bar when it comes to immunity health. The brand has made it its mission to “provide the highest quality and most effective immune supplements available on the market.”